Bottom line
What is JTMRX's expense ratio?
JTMRX's expense ratio is 0.51%, or about $51 a year on every $10,000 invested. That is cheaper than 69% of municipal bond funds we track (median 0.63%).
Updated Sep 24, 2026
JTMRX fee table
| Net expense ratio | 0.51% |
|---|---|
| Gross expense ratio | 0.54% |
| Management fee | 0.46% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.07% |
| Acquired fund fees | 0.01% |
| Fee waiver / reimbursement | -0.03% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Sep 24, 2026
What JTMRX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| JTMRX | $52 | $170 | $299 | $674 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.51% expense ratio costs roughly $29,500 in lost growth, versus about $36,000 for the median municipal bond fund (0.63%).